Free Float 98,64 %
Shares Float 28,91 M
Shares Outstanding 29,31 M
ORION NUTRACEUTICALS INC Share · CA68629J2056 · A2P45H (XCNQ) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of ORION NUTRACEUTICALS INC
No Price
Share Float & Liquidity
Company Profile for ORION NUTRACEUTICALS INC Share
Orion Nutraceuticals Inc. focuses on the drug for treating asthma and chronic obstructive pulmonary diseases in Canada. The company was formerly known as Cline Capital Corp. Orion Nutraceuticals Inc. was incorporated in 2017 and is headquartered in Vancouver, Canada.
Company Data
Name ORION NUTRACEUTICALS INC
Company Orion Nutraceuticals Inc.
Website
https://www.orionnutra.ca
Primary Exchange 
CSE LISTED
CSE LISTED
WKN A2P45H
ISIN CA68629J2056
Asset Class Share
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
CEO Joel S. Dumaresq
Market Capitalization 12 Mio
Country Canada
Currency EUR
Employees -
Address 789 West Pender Street, V6C 1H2 Vancouver
IPO Date 2018-10-17
Stock Splits
| Date | Split |
|---|---|
| 21.05.2020 | 1:25 |
Ticker Symbols
| Name | Symbol |
|---|---|
| CSE LISTED | ORI.CN |
| Frankfurt | 86OA.F |
More Shares
Investors who hold ORION NUTRACEUTICALS INC also have the following shares in their portfolio:
